New perspectives in the use of drugs that modify atypical neurotransmitters in the...
Involvement of the medial prefrontal cortex (mPFC) in the rapid and sustained effe...
Cannabidiol in the treatment of neuropsychiatric disorders: new paths
Typical and atypical neurotransmitters in neuropsychiatric disorders
The action of cannabinoid drugs in L-dopa-induced dyskinesia: analysis of neuroinf...
Investigation of the participation of the ADAM10-NEGR1-FGFR2 pathway in vitro and ...
Participation of glutamate and nitric oxide on the pathophysiology of neuropsychia...